Skip to main content
PLOS One logoLink to PLOS One
. 2026 Jan 21;21(1):e0338791. doi: 10.1371/journal.pone.0338791

Comparison of self-reported survey and wastewater-based epidemiology measures of cocaine use on a college campus

Shona McCulloch 1, Dessa Bergen-Cico 1, Teng Zeng 2, David A Larsen 1,*
Editor: Enrico Greco3
PMCID: PMC12822982  PMID: 41563979

Abstract

Background

Wastewater–based epidemiology (WBE) has the potential to produce reliable, efficient, and non-invasive measures of current psychoactive drug use. The aim of this study was to assess the feasibility and validity of using WBE to estimate current cocaine use among university students at a residential campus.

Methods

We analyzed wastewater samples from four locations at a residential university campus during spring semester of 2021, testing for cocaine metabolites in addition to control comparison substances (acetaminophen and caffeine). We simultaneously administered a confidential self-report survey of recent substance use behaviors to a randomized sample of undergraduate students at this university.

Results

Self-reported survey estimates of cocaine use and point estimates of cocaine use derived from wastewater-based epidemiology are similar, but the survey is imprecise with a wide CI, and agreement is sensitive to key WBE assumptions; thus, results are consistent but not conclusive. The self-report survey results indicated 0.13% of respondents were regular cocaine users, which is equivalent to the estimate of 0.12% of students using cocaine as measured through WBE. This prevalence is also in line with the 0.14% National American College Health Association (NACHA) survey during the same semester.

Conclusions

WBE shows promise as a complementary approach for estimating current cocaine use among students on a residential campus; with current data the WBE point estimate is similar to the survey point estimate, but uncertainty in both measures (especially the survey) requires further research.

Introduction

Cocaine is an illicit stimulant drug with a high addiction potential due to its effects on the brain’s dopaminergic pathways [1]. In addition to its risk for addiction cocaine, which is most commonly taken in powder form intranasally, cocaine can be mixed with other drugs such as amphetamines and synthetic opioids, including fentanyl, increasing the danger to users. These “polydrug cocaine combinations” that emerged concurrently with the fentanyl epidemic in 2014 in the United States are largely responsible for cocaine related overdose deaths [2]. According to the National Institute of Health (NIH) cocaine attributable deaths in the United States (U.S.) rose 54% from 2019 through 2021 with 24,486 total deaths in 2021 [3].

Historically, North America has been the largest market in the world for cocaine with an estimated 6.4 million users in 2020; however global cocaine trafficking and use has increased in recent years negatively impacting global health and playing a significant role in incarcerations and organized crime [46]. Approximately 2% of the U.S. population 12 years and older have used cocaine [5], and an estimated 1.3 million Americans struggle with cocaine use disorder (CUD) [7]. Young adults aged 18–25 years old have the highest level of cocaine use [8]. Consequently, there is a growing body of research encompassing both illicit drug (ID) and prescription drug misuse (PDM) on college campuses. University life presents multiple stressors, including academic pressure, social challenges, and financial concerns, which may contribute to substance use among students [9].

Cocaine use on college campuses varies by institution and state and is influenced by a variety of factors including physical and social environment, availability, and purpose for use (i.e., stress relief, recreation, compulsion etc.) [9]. Although the long-term impacts of repeated cocaine use are not yet fully realized [10], chronic cocaine use has been shown to cause serious cognitive deficits in working memory [11], impulsivity and control [12], and disrupted midbrain functionality [13]. Brain development during formative college years is critical and could potentially be adversely impacted by cocaine use. Therefore, understanding the extent of cocaine use on college campuses can inform public health interventions that would benefit students.

Cocaine use, like other illicit drugs, is most often a hidden behavior. The conventional method to measure the extent of drug use in a community is through self-reported surveys or data on drug seizures. Drug seizures are not sufficiently frequent to provide useful information on the prevalence of drug use in college and university communities, and many issues exist with self-reported survey methods [14]. For example, surveys are subject to numerous forms of bias, specifically social desirability, recall, and nonresponse bias. College and university students may be apprehensive to disclose drug use even when confidentiality is assured due to fear of consequences (academic or legal discipline), privacy concerns, associated stigma, or self-denial [15]. Additionally, surveys are expensive. As a complement to survey and drug seizure data, public health departments outside the U.S. have used wastewater-based epidemiology (WBE) to inform their understanding of trends in drug use since 2011 [16].

When applied to drug use, WBE involves measuring the amount of both drug residues and metabolites (collectively known as biomarkers) in a community’s wastewater. Upon ingestion, a drug may exit the body in the form of the parent substance or a metabolite through either urine or feces and subsequently enter the sewage system [17]. Since shown to be possible in the early 2000s [18], WBE has been suggested a powerful tool for monitoring illicit drug usage patterns [19]. Since then, WBE has been successfully deployed to track illicit drug use in Australia [20], Europe [21], South Africa [22], and South Korea [23]. Yet, this approach to monitoring drug use is still considered to be relatively new and has not been widely adopted outside of these contexts. Interestingly, WBE was widely used to support university and college responses to the COVID-19 pandemic [24]; however, WBE of drug use has seen a limited application at institutions of higher learning in the U.S. A few examples include the quantification of non-medical use of ADHD medication [25]; the use of psychoactive stimulants during periods of high and low stress [26]; and documenting the presence of amphetamines, opioids, cocaine, cannabinoids, fentanyl, and lysergics in college wastewater [2729].

As universities and colleges have a vested interest in the health and wellbeing of their students, including drug use behavior, it would be beneficial to better understand how WBE might compare and complement standard questionnaires about drug use in a university setting. Moreover, WBE not only has relevance for post-secondary intuitions, but also a broader social and public health significance. Herein, we compare a survey of self-reported frequency of cocaine use with the levels of cocaine metabolites (benzoylecgonine) found in wastewater at a university in the U.S. during spring semester 2021.

Methods

Setting

This study was conducted at a large university that typically enrolls about 20,000 students, the vast majority (70%) of which are undergraduate students, with over 65% of the student population living in university housing on the main campus. The residence halls are comprised of traditional style college dormitories.

Cocaine use survey

As part of a larger survey of student well-being implemented by the university between 05/04/2021 and 25/04/2021, we assessed the frequency of cocaine use among students living on campus. The university selected a random sample of the student population and sent a confidential email to the sample of 6,000 undergraduate and graduate students inviting them to participate in the health behavior survey (with an embedded survey link) during spring semester of 2021. The survey received a 33.6% response rate (n = 2013). Students taking the survey were notified that by choosing to complete the survey they were consenting to participate. The survey questionnaire was modeled after the National American College Health Assessment Survey [30]. The questions asked which substances students have used cocaine, their frequency of use, and their general social well-being. No identifying information was collected as part of the survey.

Wastewater sampling and analysis

During spring semester of 2021 wastewater surveillance was being implemented outside student residence halls (dormitories) as part of the university’s COVID-19 response plan [31]. Coinciding with the survey being distributed we pulled fourteen 24-hour composite effluent wastewater samples from 4 dormitory locations across both north and south campuses for drug analysis, with the number of samples varying by location. (Location 1 was sampled five times, location 2 was sampled six times, location 3 was sampled two times, and location 4 was sampled one time.).

Samples were filtered using 0.22 μm polyethersulfone syringe filters and analyzed in duplicate by liquid chromatography-high-resolution mass spectrometry, as detailed elsewhere [32]. Typically, 1 mL of filtered sample was loaded onto a Hypersil GOLD aQ C18 trap column (20 × 2.1 mm i.d., 12 μm) using a Thermo Scientific TriPlus RSH autosampler and liquid handling system for preconcentration and extraction. Target analytes were then eluted from the trap column for chromatographic separation by a Hypersil GOLD aQ C18 analytical column (100 × 2.1 mm, 1.9 μm; preceded with a 10 × 2.1 mm guard cartridge) on a Vanquish Horizon ultrahigh-performance liquid chromatograph. Mass spectrometric analysis was conducted in positive electrospray ionization mode on an Orbitrap Exploris 240 quadrupole-Orbitrap mass spectrometer. Target analytes were confirmed by comparing their chromatographic retention times and data-dependent mass spectra with those of reference standards. Concentrations of confirmed target analytes were quantified with reference to calibration standards. The limits of quantification for the chemical of interest are as follows: bezoylegconine (1.2 ng/L), acetaminophen (1.3 ng/L), and caffeine (6.3 ng/L) [32].

Estimating cocaine use from wastewater

We estimated the daily consumption of cocaine, as well as acetaminophen and caffeine, in milligrams per 1,000 population following the approach outlined by Wang et al (Equation 1) [33]. Due to the samples being taken from building estimates, we were unable to measure flow directly. Therefore we estimated flow from the average American wastewater discharge ranging from 190 - 265 liters per day [34]. We obtained correction factors for back calculation from a literature review of current and past WBE studies: acetaminophen 3.55 [35], benzoylecgonine (cocaine metabolite) 3.59 [33], and caffeine 14.8 [36]. The university where the samples were collected provided population counts from each dormitory. Once daily consumption was estimated, we divided the daily consumption estimate by an estimated typical dose of each drug. We used 30–70 mg for cocaine, 500–1000 mg for acetaminophen, and 95–175 mg for caffeine.

DC=(CDTR×F×CFDTRP)/TD (1)

Equation 1: DC is the daily consumption value (mg/1000 people). CDTR is the median concentration of the drug target residue or DTR (ng L-1) from the sample analysis. F is the flow rate (in liters per/day/per person). CFDTR is the correction factor [33] of the indicated DTR. P is the population size indicated to us by the University housing office. TD is the typical dose of each substance represented in mg per day or assuming one dose (benzoylecgonine).

Calculations of survey data

The survey first asked students the following questions about their use of cocaine a.) to determine if potential lifetime use: “Have you ever used - Cocaine (coke, crack, etc.); b.) to estimate recent use: “Since the start of the spring semester, how often have you used: - Cocaine (coke, crack, etc.). If students answered yes to the second question, they were asked c.) “Since the start of the spring semester, how often have you had a strong desire or urge to use the following” and responded using this Likert scale of frequency, “less than weekly”, “weekly”, “multiple times per week”, and “daily.” We classified students answering “multiple times per week” or “daily” as students using cocaine at the time of the wastewater sampling.

Ethics

This study was reviewed and found exempt by the Syracuse University IRB #21-003. A random sample of 6,000 students were invited by email to participate in a survey on student substance use, health, and well-being. The email included written informed consent which explained that no names would be obtained in the consent process to ensure anonymity. The informed consent stated “Involvement in the study is voluntary and anonymous. This means you can choose whether to participate and that you may withdraw from the study at any time without penalty. We are not asking for any personally identifiable information. By continuing with this survey, you confirm that you are 18 years of age or older and that you agree to participate in this research study.” The invited participants had the option to proceed to the survey or exit. No identifying information was gathered during the survey. The survey was conducted between 05/04/2021 and 21/04/2021.

Results

The survey was sent to 6,000 students including undergraduates and graduates, with a response rate of 33.6% (n = 2,013). Among the respondents 38% (n = 762) reported living in a campus residential dormitory. We used this segment of the survey respondents to estimate the self-report prevalence of recent cocaine use because the wastewater samples were collected from residence hall outflows. Among students living on campus cocaine use was uncommon, with more than 95% of students reporting they had never used cocaine before. Among students living in campus housing (Fig 1), 3% reported cocaine use during the semester the study was conducted. Only one student was classified as a regular user, reporting cocaine use multiple times per week, and one other student reported using cocaine weekly.

Fig 1. Frequency of self-reported cocaine use among students living on campus who reported they had ever used cocaine.

Fig 1

95% of students reported never using cocaine.

The cocaine metabolite benzoylecgonine was found in all wastewater samples across the four dormitory sampling locations (Fig 2). Raw concentrations were low, less than 100 ng/L. Acetaminophen and caffeine were also found in all wastewater samples across the four dormitory sampling locations, with concentrations 800 and 100 times greater than benzoylecgonine, respectively. Acetaminophen had the highest variability of recorded results, which translated into wide intervals of estimated users (Table 1). The reported prevalence of caffeine use was less variable but still wide, ranging from 7% − 37%. Cocaine use was estimated to be < 0.5% prevalent at all sampling locations. A total of 4.67 (95% CI = 2.18 = 7.14) doses of cocaine use was measured across all sampling locations, translating to 0.12% of students on campus using cocaine (95% CI = 0.05–0.18%).

Fig 2. Raw concentrations of the cocaine metabolite benzoylecgonine, acetaminophen, and caffeine in wastewater from four sampling points across the university campus.

Fig 2

Table 1. The number of estimated doses and population prevalence of the use of acetaminophen, benzoylecgonine, and caffeine derived through wastewater-based epidemiology.

Drug Location Number of samples Median raw concentration (ng/L); (min-max) Number of estimated doses (credibility interval) Population prevalence assuming 1 dose per person (credibility interval)
Acetaminophen Loc 1 5 27,000
(80–94,000)
35 (18–51) 9.5% (5.0–14%)
Acetaminophen Loc 2 6 49,000
(33,000–122,000)
63 (33–92) 12.8% (6.8–18.9%)
Acetaminophen Loc 3 2 26,500
(20,000–33,000)
34 (18–50) 1.7% (0.9–2.5%)
Acetaminophen Loc 4 1 1,800 2.3 (1.2–3.4) 0.2% (0.1–0.3%)
Benzoylecgonine (cocaine metabolite) Loc 1 5 50
(40–70)
1.04 (0.49–1.59) 0.3% (0.1–0.4%)
Benzoylecgonine (cocaine metabolite) Loc 2 6 55
(50–60)
1.14 (0.53–1.75) 0.2% (0.1–0.4%)
Benzoylecgonine (cocaine metabolite) Loc 3 2 60
(60−60)
1.24 (0.58–1.90) 0.06% (0.03–0.09%)
Benzoylecgonine (cocaine metabolite) Loc 4 1 60 1.24 (0.58–1.90) 0.1% (0.05–0.17%)
Caffeine Loc 1 5 4700
(190−5,100)
135 (75–194) 37% (0.21–0.54%)
Caffeine Loc 2 6 4700
(2,800−23,000)
135 (75–194) 28% (15–40%)
Caffeine Loc 3 2 4900
(4,700−5,100)
141 (79–203) 7.0% (3.9–10.1%)
Caffeine Loc 4 1 6800 195 (109–281) 18% (9.9–26%)

Discussion

In our analysis, we found that self-reported survey estimates of cocaine use among those who reported frequent regular use presented similarly to point estimates of cocaine use derived from wastewater-based epidemiology. The self-report survey results indicated according to our criteria only 1 out of 762 students to be a regular cocaine user (0.13%). This result was equivalent to the estimate of 0.12% of students regularly using cocaine as measured through wastewater-based epidemiology. A prevalence of use of 0.12-0.13% is in line with a recent American College Health Association (ACHA), National College Assessment III [37], which found regular cocaine use across college campuses to be 0.14%.

The use of acetaminophen and caffeine derived from wastewater-based epidemiology were much more variable than we expected. A recent study of the use of pain medications at the city-level showed similar percentages of acetaminophen use to two of the locations we sampled [35], however the other two locations we sampled had estimated prevalence of acetaminophen use well below 1%. These two sampling locations also had the lowest estimated caffeine and cocaine use, perhaps indicating an issue in the sampling locations themselves.

Given the sample size of the ACHA data set, seeing that our results were close to what they found cocaine use to be, is very encouraging but could have also happened by chance. In our data analysis, we only had one person during spring semester classified as a cocaine “regular user.” With only 1 user out of 762, we were not able to perform any kind of advanced statistical analyses to identify risk factors with current cocaine use. Another limitation of our study were the various assumptions that had to be made in our initial daily consumption (DC) equation. These assumptions included the median flow rate (F) (which was based off a government study from 2002) and the typical dose (TD) for each substance (i.e., the dose size or frequency of cocaine administration). We inferred a typical dose size but not have any data from our study. Additionally, the survey asked about cocaine use throughout the semester, and we only tested wastewater for cocaine use during the survey period. This temporal misalignment precluded us from testing wastewater for known cocaine use at the time of the survey. The agreements between WBE and self-reported cocaine use that we’ve observed could be coincidental.

As in any WBE study, uncertainties revolve around establishing a standardized correction factor for DTRs, considering the loss of biomarkers in metabolic processing as well as additional interactions with different substances in sewer systems [38]. Our study design was cross sectional and only captured usage data from a single period to determine the exposure of drug use on campus. We are limited by the number of samples from spring semester 2021 and we cannot infer spatial or temporal patterns from this data, nor did we attempt any investigation into the reason why cocaine is being used on this campus [39]. Considering the study design and implementation, our study is perhaps not representative of the entire campus.

The strengths of wastewater-based epidemiology allow researchers to obtain drug use information without breaching the personal privacy of students and avoid the issues which can be encountered with self-report survey-based research. In a recent meta-analysis examining the relationship between self-reported drug use and wastewater samples [40], it was found that the agreement between the two measures were consistently high, suggesting both are equally good methods of obtaining reliable data. The relationship tended to be stronger when research participants were informed they would not face any repercussions for reporting drug use, with an emphasis on cocaine usage.

This study confirmed the viability of WBE as a public health tool to complement existing methods of obtaining drug use information, particularly on college campuses. Future research could expand to multiple drugs of interest such as various opioids, cannabis, and amphetamine type stimulants. It would also be pertinent to have a flow volume which is specific to the population rather than a best approximation based on previous studies. If this study were to be replicated, multiple wastewater sample collections across the semester or academic year and would enable researchers to gain a better understanding of student population level cocaine use. Collecting samples over time (ex. monthly over the semester) may better capture the population level of cocaine use because cocaine’s metabolite benzoylecgonine is only detectable in urine for about 72–98 hours after last use [41]. Collecting and analyzing wastewater samples over the course of a semester may yield an estimate closer to the residential student population self-reported usage rate of 3% during the semester.

WBE can be a useful to obtain noninvasive drug use data, and with this in mind, future research should adopt a longitudinal study design to evaluate spatial and temporal patterns of use. Having a tool which can give colleges and universities an idea of temporal patterns of use, may enable them to design appropriate strengths-based interventions, to optimize student mental health and wellbeing. It is important then when taking samples from dormitories and residence halls on campus, that the data be handled with caution, as the mishandling of such data may inadvertently stigmatize a certain residence where high drug usage may be detected.

Supporting information

S1 File. Wastewater data.

(XLSX)

pone.0338791.s001.xlsx (11.7KB, xlsx)
S2 File. Survey data.

(XLSX)

pone.0338791.s002.xlsx (17.9KB, xlsx)

Acknowledgments

We thank Dr. Shiru Wang (Syracuse University) for her contribution to sample analysis. This study was approved by Syracuse University’s IRB. IRB # 21-003.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

TZ received funding from the National Science Foundation, award number 2018497.

References

  • 1.Chamberlain SR, Lust K, Grant JE. Cocaine use in university students: relationships with demographics, mental health, risky sexual practices, and trait impulsivity. CNS Spectr. 2020;26(5):501–8. doi: 10.1017/s1092852920001492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.U.S Department of Justice. 2020 Drug enforcement adminstration national drug threat assessment. 2021. Available from: https://www.dea.gov/sites/default/files/2021-02/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf
  • 3.National Institute of Health. Drug overdose death rates. In: National Institute on Drug Abuse [Internet]. Available from: https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates#:~:text=The%20number%20of%20deaths%20involving%20cocaine%20has%20also%20increased%20steadily,in%202021%20(Figure%208)
  • 4.Lai FY, O’Brien JW, Thai PK, Hall W, Chan G, Bruno R, et al. Cocaine, MDMA and methamphetamine residues in wastewater: Consumption trends (2009-2015) in South East Queensland, Australia. Sci Total Environ. 2016;568:803–9. doi: 10.1016/j.scitotenv.2016.05.181 [DOI] [PubMed] [Google Scholar]
  • 5.United Nations Office on Drug and Crime. World Drug Report 2022: Drug Market Trends: Cocaine, Amphetamine Type Stimulants, New Psychoactive Substances. 2022. Available from: https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_4.pdf
  • 6.Taxy S, Samuels J, Adams W. Drug offenders in federal prison: Estimates of charactertistcs based on linked data. In: U.S Deaprtment of Justice [Internet]. 2015. Available from: https://bjs.ojp.gov/content/pub/pdf/dofp12.pdf
  • 7.SAMHSA. Key substance use and mental health indicators in the United States: Results from the 2020 National survey on drug use and health. 2021. Available from: https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf
  • 8.UNODC. Global report on cocaine 2023 - local dynamics, global challenges. United Nations publications. [Google Scholar]
  • 9.Schwartz EKC, Wolkowicz NR, De Aquino JP, MacLean RR, Sofuoglu M. Cocaine use disorder (CUD): current clinical perspectives. Subst Abuse Rehabil. 2022;13:25–46. doi: 10.2147/SAR.S337338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Frazer KM, Richards Q, Keith DR. The long-term effects of cocaine use on cognitive functioning: a systematic critical review. Behav Brain Res. 2018;348:241–62. doi: 10.1016/j.bbr.2018.04.005 [DOI] [PubMed] [Google Scholar]
  • 11.Bustamante J-C, Barrós-Loscertales A, Ventura-Campos N, Sanjuán A, Llopis J-J, Parcet M-A, et al. Right parietal hypoactivation in a cocaine-dependent group during a verbal working memory task. Brain Res. 2011;1375:111–9. doi: 10.1016/j.brainres.2010.12.042 [DOI] [PubMed] [Google Scholar]
  • 12.Fernández-Serrano MJ, Perales JC, Moreno-López L, Pérez-García M, Verdejo-García A. Neuropsychological profiling of impulsivity and compulsivity in cocaine dependent individuals. Psychopharmacology (Berl). 2012;219(2):673–83. doi: 10.1007/s00213-011-2485-z [DOI] [PubMed] [Google Scholar]
  • 13.Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, Alia-Klein N, et al. Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS One. 2010;5(5):e10815. doi: 10.1371/journal.pone.0010815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Baz-Lomba JA, Salvatore S, Gracia-Lor E, Bade R, Castiglioni S, Castrignanò E, et al. Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities. BMC Public Health. 2016;16(1):1035. doi: 10.1186/s12889-016-3686-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Johnson TP. Sources of error in substance use prevalence surveys. Int Scholar Res Not. 2014;2014:1–21. doi: 10.1155/2014/923290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.González-Mariño I, Baz-Lomba JA, Alygizakis NA, Andrés-Costa MJ, Bade R, Bannwarth A, et al. Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring. Addiction. 2020;115(1):109–20. doi: 10.1111/add.14767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gracia-Lor E, Castiglioni S, Bade R, Been F, Castrignanò E, Covaci A, et al. Measuring biomarkers in wastewater as a new source of epidemiological information: current state and future perspectives. Environ Int. 2017;99:131–50. doi: 10.1016/j.envint.2016.12.016 [DOI] [PubMed] [Google Scholar]
  • 18.Zuccato E, Chiabrando C, Castiglioni S, Calamari D, Bagnati R, Schiarea S, et al. Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health. 2005;4:14. doi: 10.1186/1476-069X-4-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lancaster K, Rhodes T, Valentine K, Ritter A. A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis in the context of illicit drug epidemiology and drug policy. Cur Opin Environ Sci Health. 2019;9:85–90. doi: 10.1016/j.coesh.2019.06.006 [DOI] [Google Scholar]
  • 20.Australian Criminal Intelligence Commission. National wastewater drug monitoring program: Report 22. 2024. [Google Scholar]
  • 21.Ryu Y, Barceló D, Barron LP, Bijlsma L, Castiglioni S, de Voogt P, et al. Comparative measurement and quantitative risk assessment of alcohol consumption through wastewater-based epidemiology: an international study in 20 cities. Sci Total Environ. 2016;565:977–83. doi: 10.1016/j.scitotenv.2016.04.138 [DOI] [PubMed] [Google Scholar]
  • 22.Archer E, Castrignanò E, Kasprzyk-Hordern B, Wolfaardt GM. Wastewater-based epidemiology and enantiomeric profiling for drugs of abuse in South African wastewaters. Sci Total Environ. 2018;625:792–800. doi: 10.1016/j.scitotenv.2017.12.269 [DOI] [PubMed] [Google Scholar]
  • 23.Lee H-J, Oh J-E. Target and suspect screening of (new) psychoactive substances in South Korean wastewater by LC-HRMS. Sci Total Environ. 2023;875:162613. doi: 10.1016/j.scitotenv.2023.162613 [DOI] [PubMed] [Google Scholar]
  • 24.Harris-Lovett S, Nelson KL, Beamer P, Bischel HN, Bivins A, Bruder A, et al. Wastewater surveillance for SARS-CoV-2 on college campuses: initial efforts, lessons learned, and research needs. Int J Environ Res Public Health. 2021;18(9):4455. doi: 10.3390/ijerph18094455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Burgard DA, Fuller R, Becker B, Ferrell R, Dinglasan-Panlilio MJ. Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: wastewater analysis of amphetamine and ritalinic acid. Sci Total Environ. 2013;450–451:242–9. doi: 10.1016/j.scitotenv.2013.02.020 [DOI] [PubMed] [Google Scholar]
  • 26.Moore DR, Burgard DA, Larson RG, Ferm M. Psychostimulant use among college students during periods of high and low stress: an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addict Behav. 2014;39(5):987–93. doi: 10.1016/j.addbeh.2014.01.021 [DOI] [PubMed] [Google Scholar]
  • 27.Heuett NV, Ramirez CE, Fernandez A, Gardinali PR. Analysis of drugs of abuse by online SPE-LC high resolution mass spectrometry: communal assessment of consumption. Sci Total Environ. 2015;511:319–30. doi: 10.1016/j.scitotenv.2014.12.043 [DOI] [PubMed] [Google Scholar]
  • 28.Panawennage D, Castiglioni S, Zuccato E, Davoli E, Paul Chiarelli M. Measurement of illicit drug consumption in small populations: prognosis for noninvasive drug testing of student populations. Illicit Drugs in the Environment. John Wiley & Sons, Ltd; 2011. pp. 321–331. doi: 10.1002/9781118000816.ch18 [DOI] [Google Scholar]
  • 29.Gushgari AJ, Driver EM, Steele JC, Halden RU. Tracking narcotics consumption at a Southwestern U.S. university campus by wastewater-based epidemiology. J Hazard Mater. 2018;359:437–44. doi: 10.1016/j.jhazmat.2018.07.073 [DOI] [PubMed] [Google Scholar]
  • 30.American College Health Association. National College Health Assessment. 2019. Available from: https://www.acha.org/documents/ncha/ACHA-NCHA_IIc_Web_Survey_2011_SAMPLE.pdf
  • 31.Godinez A, Hill D, Dandaraw B, Green H, Kilaru P, Middleton F, et al. High sensitivity and specificity of dormitory-level wastewater surveillance for COVID-19 during fall semester 2020 at Syracuse University, New York. Int J Environ Res Public Health. 2022;19(8):4851. doi: 10.3390/ijerph19084851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Vogel EJ, Neyra M, Larsen DA, Zeng T. Target and nontarget screening to support capacity scaling for substance use assessment through a statewide wastewater surveillance network in New York. Environ Sci Technol. 2024;58(19):8518–30. doi: 10.1021/acs.est.4c01251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wang H, Xu B, Yang L, Huo T, Bai D, An Q, et al. Consumption of common illicit drugs in twenty-one cities in southwest China through wastewater analysis. Sci Total Environ. 2022;851(Pt 1):158105. doi: 10.1016/j.scitotenv.2022.158105 [DOI] [PubMed] [Google Scholar]
  • 34.Benefield L. Rule development commitee isssue research report draft – residential flow rates. 2002. Available from: https://doh.wa.gov/sites/default/files/legacy/Documents/Pubs//337-103.pdf
  • 35.Kannan A, Sims N, Hold AJ, Jagadeesan K, Standerwick R, Barden R, et al. The burden of city’s pain treatment - a longitudinal one year study of two cities via wastewater-based epidemiology. Water Res. 2023;229:119391. doi: 10.1016/j.watres.2022.119391 [DOI] [PubMed] [Google Scholar]
  • 36.Gracia-Lor E, Rousis NI, Zuccato E, Bade R, Baz-Lomba JA, Castrignanò E, et al. Estimation of caffeine intake from analysis of caffeine metabolites in wastewater. Sci Total Environ. 2017;609:1582–8. doi: 10.1016/j.scitotenv.2017.07.258 [DOI] [PubMed] [Google Scholar]
  • 37.American College Health Association. Undergraduate Student Reference Group Data Report Spring 2021. Available from: https://www.acha.org/documents/ncha/NCHA-III_SPRING-2021_UNDERGRADUATE_REFERENCE_GROUP_DATA_REPORT.pdf
  • 38.Lorenzo M, Picó Y. Wastewater-based epidemiology: current status and future prospects. Curr Opin Environ Sci Health. 2019;9:77–84. doi: 10.1016/j.coesh.2019.05.007 [DOI] [Google Scholar]
  • 39.Levin KA. Study design III: Cross-sectional studies. Evid Based Dent. 2006;7(1):24–5. doi: 10.1038/sj.ebd.6400375 [DOI] [PubMed] [Google Scholar]
  • 40.Bharat C, Webb P, Wilkinson Z, McKetin R, Grebely J, Farrell M, et al. Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis. Addiction. 2023;118(9):1624–48. doi: 10.1111/add.16200 [DOI] [PubMed] [Google Scholar]
  • 41.Smith ML, Shimomura E, Paul BD, Cone EJ, Darwin WD, Huestis MA. Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. J Anal Toxicol. 2010;34(2):57–63. doi: 10.1093/jat/34.2.57 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Enrico Greco

8 Oct 2025

Dear Dr. Larsen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Enrico Greco

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. Thank you for stating the following financial disclosure:

 “TZ received funding from the National Science Foundation, award number 2018497” 

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The authors compare estimate of cocaine use from benzoylecgonine concentrations in 14 24-hour composite wastewater samples collected from four dormitory sewages with results from a student self-report survey (n = 2,013 respondents; 762 dormitory residents). They conclude that wastewater-based epidemiology (WBE) and self-reported data give similar prevalence estimates (~ 0.12 - 0.13%). The manuscript is technically competent in the laboratory analysis, but the statistical treatment and handling of uncertainty in the comparison require strengthening.

Specific comments:

1. Abstract:

in the conclusion, the sentence “WBE is a feasible and valid of method” should be replaced with a more cautious statement, such as: “WBE shows promise as a complementary approach; with current data the WBE point estimate is similar to the survey point estimate, but uncertainty in both measures (especially the survey) is large, and further work is required.”

2. The extended possessive form is preferable:

Line 28: “…on the brain’s dopaminergic pathways…”

Line 36: “…world’s largest…”

Line 66: “…community’s wastewater…”

Line 104: “…university’s COVID-19…”

Line 221: “…cocaine’s metabolite…”

Line 224: “…residential population’s self-reported usage…”

3. Line 39: There is an error in the reference “[UNODC, 2023]”

4. Line 39: missing period in “U.S.”

5. Line 42-44: university life is not the only stressor, according to reference [9]

6. Line 62-64: the reference for this sentence is missing

7. Line 79-84: The aim of the study could be expanded. Specifically, the manuscript could test whether WBE is truly capable of providing an overview of cocaine use within college settings. Moreover, this issue has not only institutional relevance for universities and colleges, but also broader social and public health significance.

8. “Cocaine use survey” section:

The manuscript should clarify how many students received the survey invitation email. This information should be included not only in the “Results” section but also in the “Materials and methods”.

9. “Wastewater sampling and analysis” section:

The manuscript should specify how the 14 are distributed across the four dormitories. In addition, it would be valuable to report the number of residents in each dormitory, in order to assess whether these are comparable.

Comments:

10. Comparative framework:

The comparison of single-point WBE estimates (14 daily composites across four locations) with survey responses covering an entire semester is problematic. The survey asks about behavior “since the start of the spring semester” and defines regular users as those reporting use “multiple times per week/daily.” By contrast, WBE captures only a limited number of 24-hour composites. This temporal mismatch, combined with sparse WBE sampling, introduces considerable variability: benzoylecgonine is detectable for approximately 3–4 days post-use, and a small number of users can substantially affect daily loads. The authors should acknowledge that observed agreement between methods could be coincidental, given the short WBE sampling window.

The paper states that estimates “aligned”, but given the methodological imprecision described above, the authors should either (a) present explicit overlapping confidence intervals, or (b) conduct a probabilistic equivalence test. As presented, the textual claim of equivalence is weak.

11. Avoid over-strong language by replacing words such as “aligned” / “equivalent” with a statement like: “Point estimates are similar, but the survey estimate is imprecise (wide CI) and agreement is sensitive to key WBE assumptions; thus results are consistent but not conclusive.” Include both intervals in the Discussion section.

Overall evaluation:

The study is conceptually strong, methodologically promising, and well-motivated. However, the current statistical treatment of uncertainty and the strength of the comparison between WBE and survey data are limited. Incorporating the suggested clarifications, explicitly presenting uncertainty intervals, and adopting a more cautious interpretation would substantially strengthen the manuscript and allow the claims to be presented more transparently.

Reviewer #2: The proposed paper of McCulloch and co-workers presents an interesting case study of wastewater-based epidemiology; significant weakpoints are present, both in the model for estimating drug dose consumption - presenting a number of assumptions - and in extension of sampling; authors are well aware of such points and highlight them as points of attention. I ask (1) to report in the text Limit of Quantification for benzoylegconine, acetaminophen and caffeine).- and (2) at least in the supplemental material - a table with complete basic statistics of 14 samples for each sampling site for the three considered analytes (n, average, min, max).

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Jan 21;21(1):e0338791. doi: 10.1371/journal.pone.0338791.r002

Author response to Decision Letter 1


25 Nov 2025

Thank you for the review of our manuscript. We have responded to each of the reviewers' questions and suggestions. Their points are copied here with our response directly underneath.

Editor:

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you for the guidance. We have updated the manuscript according to the style guides.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

We have updated the manuscript with the ethics information required. We have included the following paragraph:

“A random sample of 6,000 students were invited by email to participate in a survey on student substance use, health, and well-being. The email included written informed consent which explained that no names would be obtained in the consent process to ensure anonymity. The informed consent stated: “Involvement in the study is voluntary and anonymous. This means you can choose whether to participate and that you may withdraw from the study at any time without penalty. We are not asking for any personally identifiable information. By continuing with this survey, you confirm that you are 18 years of age or older and that you agree to participate in this research study.”

3. Thank you for stating the following financial disclosure:

“TZ received funding from the National Science Foundation, award number 2018497”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

We have updated the financial disclosure as indicated.

4. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

Thank you for the guidance. We have removed the funding statement from the manuscript.

5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

Thank you for the guidance. All authors are agreed in making the data publicly available.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Thank you for the guidance. We do not have any supporting information files.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Thank you for the guidance. The reviewers did not recommend any citations.

Reviewer #1: The authors compare estimate of cocaine use from benzoylecgonine concentrations in 14 24-hour composite wastewater samples collected from four dormitory sewages with results from a student self-report survey (n = 2,013 respondents; 762 dormitory residents). They conclude that wastewater-based epidemiology (WBE) and self-reported data give similar prevalence estimates (~ 0.12 - 0.13%). The manuscript is technically competent in the laboratory analysis, but the statistical treatment and handling of uncertainty in the comparison require strengthening. Specific comments:

1. Abstract:

In the conclusion, the sentence “WBE is a feasible and valid of method” should be replaced with a more cautious statement, such as: “WBE shows promise as a complementary approach; with current data the WBE point estimate is similar to the survey point estimate, but uncertainty in both measures (especially the survey) is large, and further work is required.”

Thank you for the recommendation. We have replaced the sentence “WBE is a feasible and valid of method,” with the recommended cautious statement: “WBE shows promise as a complementary approach; with current data the WBE point estimate is similar to the survey point estimate, but uncertainty in both measures (especially the survey) is large, and further work is required.”

2. The extended possessive form is preferable:

Line 28: “…on the brain’s dopaminergic pathways…”

Cocaine is an illicit stimulant drug with a high addiction potential due to its effects on the pathways of the [DAL1] brain’s dopaminergic system [1].”

Line 36: “…world’s largest…”

“Historically, North America has been the largest market in the world for cocaine with an estimated 6.4 million users in 2020;”

Line 66: “…community’s wastewater…”

Line 104: “…university’s COVID-19…”

Line 221: “…cocaine’s metabolite…”

Line 224: “…residential population’s self-reported usage…”

Thank you for the recommendation. We have a difference in writing style from the reviewer. We have gone ahead and changed some of these but not others.

3. Line 39: There is an error in the reference “[UNODC, 2023]”

Thank you for catching this error. We’ve removed the “[UNODC, 2023]” – that reference is captured as reference 5 in the manuscript.

4. Line 39: missing period in “U.S.”

Thank you for catching this. We have added the missing period to the “U.S.”

5. Line 42-44: university life is not the only stressor, according to reference [9]

Yes, we agree with the reviewer that there multiple stressors. We have revised this sentence to state that university life presents multiple stressors.

6. Line 62-64: the reference for this sentence is missing

Thank you for the recommendation. We have revised this sentence to show that this is primarily ocurring outside the US and cited a longitudinal study from the SCORE network.

7. Line 79-84: The aim of the study could be expanded. Specifically, the manuscript could test whether WBE is truly capable of providing an overview of cocaine use within college settings. Moreover, this issue has not only institutional relevance for universities and colleges, but also broader social and public health significance.

Thank you for the suggestion. Unfortunately we determined the aim of the study before data collection and writing the manuscript. Herein we can only how comparable WBE is to self reported survey measures. We have added a new sentence to the paragraph in question: “Moreover, WBE not only has relevance for post-secondary institutions, but also a broader social and public health significance.”

8. “Cocaine use survey” section:

The manuscript should clarify how many students received the survey invitation email. This information should be included not only in the “Results” section but also in the “Materials and methods”.

Thank you for the recommendation. We have added the number of students receiving the survey as suggested.

9. “Wastewater sampling and analysis” section:

The manuscript should specify how the 4 are distributed across the four dormitories. In addition, it would be valuable to report the number of residents in each dormitory, in order to assess whether these are comparable.

Thank you for the suggestions. We’ve added the detail on how many samples per location. Unfortunately the number of residents in each dormitory would identify the dormitory at Syracuse University and so we cannot report on that information.

10. Comparative framework:

The comparison of single-point WBE estimates (14 daily composites across four locations) with survey responses covering an entire semester is problematic. The survey asks about behavior “since the start of the spring semester” and defines regular users as those reporting use “multiple times per week/daily.” By contrast, WBE captures only a limited number of 24-hour composites. This temporal mismatch, combined with sparse WBE sampling, introduces considerable variability: benzoylecgonine is detectable for approximately 3–4 days post-use, and a small number of users can substantially affect daily loads. The authors should acknowledge that observed agreement between methods could be coincidental, given the short WBE sampling window.

The paper states that estimates “aligned”, but given the methodological imprecision described above, the authors should either (a) present explicit overlapping confidence intervals, or (b) conduct a probabilistic equivalence test. As presented, the textual claim of equivalence is weak.

Thank you for the recommendation. This is certainly a limitation to the study and we have added this limitation to our limitations paragraph. We have also revised the first sentence of the discussion to say “presented similarly” rather than “alligned”. The limitations paragraph now has the following:

“Additionally, the survey asked about cocaine use throughout the semester, and we only tested wastewater for cocaine use during the survey period. This temporal misalignment precluded us from testing wastewater for known cocaine use at the time of the survey. The agreements between WBE and self-reported cocaine use that we’ve observed could be coincidental.”

11. Avoid over-strong language by replacing words such as “aligned” / “equivalent” with a statement like: “Point estimates are similar, but the survey estimate is imprecise (wide CI) and agreement is sensitive to key WBE assumptions; thus results are consistent but not conclusive.” Include both intervals in the Discussion section.

Thank you for the recommendations. We’ve replaced the term “aligned” with the following sentence in the “Results” summary in the abstract: “Self-reported survey estimates of cocaine use and point estimates of cocaine use derived from wastewater-based epidemiology are similar, but the survey is imprecise with a wide CI, and agreement is sensitive to key WBE assumptions; thus, results are consistent but not conclusive.” We also replaced the term “aligned” with “presented similarly to,” in the “Discussion” section.

Overall evaluation: The study is conceptually strong, methodologically promising, and well-motivated. However, the current statistical treatment of uncertainty and the strength of the comparison between WBE and survey data are limited. Incorporating the suggested clarifications, explicitly presenting uncertainty intervals, and adopting a more cautious interpretation would substantially strengthen the manuscript and allow the claims to be presented more transparently.

Thank you for your time in reviewing our manuscript. We would be happy to further revise if needed.

Reviewer #2: The proposed paper of McCulloch and co-workers presents an interesting case study of wastewater-based epidemiology; significant weakpoints are present, both in the model for estimating drug dose consumption - presenting a number of assumptions - and in extension of sampling; authors are well aware of such points and highlight them as points of attention. I ask (1) to report in the text Limit of Quantification for benzoylegconine, acetaminophen and caffeine).- and (2) at least in the supplemental material - a table with complete basic statistics of 14 samples for each sampling site for the three considered analytes (n, average, min, max).

Thank you for the review of our manuscript.

1) We have added a sentence to the methods section with the limits of quantification for each of the chemicals tested.

2) We have added the complete basic statistics for the samples to table 1 as suggested.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0338791.s004.docx (57.9KB, docx)

Decision Letter 1

Enrico Greco

28 Nov 2025

Comparison of self-reported survey and wastewater-based epidemiology measures of cocaine use on a college campus

PONE-D-25-45699R1

Dear Dr. Larsen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Enrico Greco

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Enrico Greco

PONE-D-25-45699R1

PLOS One

Dear Dr. Larsen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Enrico Greco

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Wastewater data.

    (XLSX)

    pone.0338791.s001.xlsx (11.7KB, xlsx)
    S2 File. Survey data.

    (XLSX)

    pone.0338791.s002.xlsx (17.9KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0338791.s004.docx (57.9KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES